Overview Stress Echocardiography Study With Regadenoson Status: Terminated Trial end date: 2010-04-01 Target enrollment: Participant gender: Summary Regadenoson is approved in the US under the brand name Lexiscan for myocardial perfusion imaging. This study will test whether regadenoson is an appropriate stress agent for stress echocardiography. Phase: Phase 2 Details Lead Sponsor: Gilead SciencesTreatments: Regadenoson